Literature DB >> 21332604

HCMV gB genotype and its association with cytokine levels in hematopoietic stem cell transplantation.

J F Correia-Silva1, R G Resende, T C Arão, M H N G Abreu, M M Teixeira, H Bittencourt, T A Silva, R S Gomez.   

Abstract

BACKGROUND: Glycoprotein B (gB) has been implicated in determining the pathogenicity and clinical outcomes of human cytomegalovirus (HCMV) disease.
OBJECTIVE: The purpose of this study was to assess the prevalence of gB genotypes in allogeneic hematopoietic stem cell transplantation (allo-HSCT) and the relationship between it and cytokine levels in saliva and blood samples. The impact of these parameters on patients' survival was also investigated.
METHODS: Samples were obtained from 63 patients receiving an allo-HSCT. HCMV gB genotyping was carried out by multiplex nested PCR. The cytokine levels were assessed using ELISA assay.
RESULTS: A single or mixed genotype infection was detected in the saliva and blood of 36/63 and 52/63 subjects, respectively. Patients with gB2 in their saliva showed lower IL-10 levels in comparison with patients without gB2. Reduced blood levels of IFN-γ and IL-1β were also found in recipients with the HCMV gB4 genotype compared with patients without it. Decreased IL-1β and increased IL-10 blood levels were associated with lower survival. However, HCMV gB genotypes have no impact on patient outcome.
CONCLUSION: Decreased IL-1β and increased IL-10 levels in the blood are associated with lower survival. HCMV genotypes are associated with different cytokine levels in saliva and blood.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21332604     DOI: 10.1111/j.1601-0825.2011.01801.x

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  4 in total

1.  High-throughput analysis of human cytomegalovirus genome diversity highlights the widespread occurrence of gene-disrupting mutations and pervasive recombination.

Authors:  Steven Sijmons; Kim Thys; Mirabeau Mbong Ngwese; Ellen Van Damme; Jan Dvorak; Marnix Van Loock; Guangdi Li; Ruth Tachezy; Laurent Busson; Jeroen Aerssens; Marc Van Ranst; Piet Maes
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

2.  Glycoprotein B genotyping of human cytomegalovirus strains isolated from Brazilian patients with sickle cell disease and beta-thalassemia major.

Authors:  Svetoslav N Slavov; Simone Kashima; Virginia M D Wagatsuma; Ana Cristina Silva-Pinto; Edson Z Martinez; Maria do Carmo Favarin; Dimas T Covas
Journal:  Viral Immunol       Date:  2014-11-24       Impact factor: 2.257

3.  Development of two potential diagnostic monoclonal antibodies against human cytomegalovirus glycoprotein B.

Authors:  Fan Jun; Li Minhuan; Ma Yadan; Huang Yaping; Liang Hanying; Hu Jianhua; Yao Hangping; Ma Weihang
Journal:  Braz J Med Biol Res       Date:  2012-05-24       Impact factor: 2.590

Review 4.  Common Polymorphisms in the Glycoproteins of Human Cytomegalovirus and Associated Strain-Specific Immunity.

Authors:  Hsuan-Yuan Wang; Sarah M Valencia; Susanne P Pfeifer; Jeffrey D Jensen; Timothy F Kowalik; Sallie R Permar
Journal:  Viruses       Date:  2021-06-09       Impact factor: 5.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.